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Abstract 
Background: To determine operating time, blood 
loss, postoperative rise in platelet count, need of 
conversion to open surgery, postoperative hospital 
stay and postoperative complications in ITP patients 
undergoing laparoscopic splenectomy. 
Methods:  In this cross-sectional study patients 
diagnosed with ITP undergoing laparoscopic 
splenectomy  were included. Patient characteristics 
regarding operating time, blood loss, postoperative 
hospital stay, conversion to open surgery, 
postoperative complications and postoperative rise 
in platelet count were analyzed.. 
Results: Out of 23 patients, 9 were males and 14 
were females. The mean age of the patients was 31±7 
years. There was 1 conversion to open surgery. The 
mean operating time was 90±22 mins and mean 
blood loss 131±55 ml. 21 out of 23 (91.3%) patients 
showed a positive response of rise in platelet count 
after surgery. There was no postoperative 
complication in any patient. The mean postoperative 
hospital stay was 3±1 days. 
Conclusion: Laparoscopic splenectomy is 
associated with less operating time, postoperative 
hospital stay, blood loss and postoperative 
complications. It produces adequate postoperative 
rise in platelet count.  
Key Words: Laparoscopic splenectomy,  Immune 
Thrombocytopenic  Purpura,ITP, Operative time 
 
Introduction 
Immune thrombocytopenia (ITP) is an autoimmune 
disease resulting in increased platelet degradation 
with platelet count lower than 100,000/µL.1-3 The 
widely accepted mechanism involved is opsonization 
of the platelets by autoantibodies followed by 
engulfment and subsequent degradation of platelets 
by the macrophages, mainly in the spleen.4 Spleen is 
the predominant site where these autoantibodies are 
produced.5 Serologic techniques have revealed that 
these antibodies are directed against the platelet 
glycoprotein IIb/IIIa.6 Recent studies suggest that T 
cells also have a role in the pathogenesis of immune 
thrombocytopenia.7,8 ITP occurs in about 4 per 100,000 
people per year7 and may cause fatal hemorrhage.9 
Patients usually present with petechiae, purpura and 
bruising.10 Risk of death due to bleeding is around 1.6-
3.9% per year.11 
Corticosteroids are being used as a first-line treatment 
in ITP since 1950s, when it was first 
introduced.7,12However, a long-term response is seen 
in only 20-40% of patients.13 Therefore, splenectomy is 
considered as a second-line therapy for those who do 
not respond to steroids, or if steroids are 
contraindicated in the patient.14,15 In contrast to 
steroids, splenectomy produces better results with an 
early response rate of 85-88%.16 
There are two methods of splenectomy; open and 
laparoscopic.1,2 Delaitre17documented the first 
laparoscopic splenectomy in early 1990s and since then 
it is considered to be a safe procedure.17,18 It is 
preferred over open splenectomy because it is 
associated with less postoperative pain, shorter 
hospital stay, less blood loss and fewer 
complications.9,19,20 With laparoscopic splenectomy 
being considered as a  better treatment for ITP and 
preferred over open approach by many surgeons, 
developing countries like Pakistan, where traditional 
procedures are still widely practiced, should take a 
note. 19 
 
Patients and Methods 
This cross-sectional study was conducted in the 
surgery department of Holy Family Hospital, 
Rawalpindi and Bilal Hospital, Rawalpindi from 2010 
till 2017. The subjects of this study were 23 patients 
who underwent laparoscopic splenectomy for ITP at 
the two above mentioned hospitals. All these patients 
were non-responders  to steroid therapy and each case 
was discussed with haematologists and physicians for 
the decision of splenectomy (which was laparoscopic 
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splenectomy in all cases). Patient characteristics were 
studied and data regarding operating time, blood loss, 
postoperative hospital stay, conversion to open 
surgery, postoperative complications and 
postoperative rise in platelet count. Each candidate for 
laparoscopic splenectomy had a platelet count < 
50,000/µL before surgery.A postoperative platelet 
count ≥ 100,000/µL was considered to be a positive 
response. 
All patients were given a course of vaccination against 
Pneumococcus, Meningococcus and H. influenzae two 
weeks before surgery. Platelet transfusions were 
avoided before surgery unless clearly indicated. 
Laparoscopic splenectomy was performed with the 
patient placed in reverse Trendelenburg position, with 
elevation of left side. The surgeon and the 
laparoscopist stood on the right side of the patient and 
the assistant on the left side. Colosplenic, gastrosplenic 
and splenophrenic ligaments were separated using 
harmonic scalpel technology (figure 1.) and hilar 
vessels clipped carefully, avoiding injury to the 
pancreatic tail (figure 2.).  
 
    
 
 
 
 
 
 
 
    
 
 
 
 
 
At the time of splenic artery ligation, platelets were 
transfused. The resected spleen was then placed into 
an Endo-Catch II self-expanding bag (figure 3.). In 
some cases sterile gloves were used to deliver spleen 
(figure 4.). The bag was partially pulled out and the 
spleen crushed and removed. 
 
Results 
Out of 23 patients undergoing laparoscopic 
splenectomy, 9 were males and 14 were females. The 
age of the patients ranged from 17 – 45years and the 
mean age was 31±7 years (Table 1). There was only 1 
case in which conversion to open splenectomy became 
necessary due to excessive blood loss (>250 ml). The 
mean operating time was 90±22 mins and mean blood 
loss 131±55 ml. 21 out of 23 (91.3%) patients showed a 
positive response of rise in platelet count after surgery. 
There was no postoperative complication in any 
patient. The mean postoperative hospital stay was 3±1 
days (Table 2).  
 
Table 1: Demographic data of patients 
 No. of patients Percentage (%) 
Gender 
Male 9  39.1 
Female 14  60.9 
Age of patients(years) 
17 – 22  2  8.7 
23 – 28  4  17.4 
29 – 34  11  47.8 
35 – 40  4 17.4 
41 – 46 2  8.7 
Table 2: Clinical characteristics and surgical 
profile of patients 
Characteristic No(%) 
Operating Time (minutes) 
35-59 2 (8.7) 
60-84 8(34.8) 
85-109 9(39.1) 
110-134 3(13.0) 
135-159 1(4.4) 
Blood loss (ml) 
55-99 8(34.8) 
100-144 7(30.4) 
145-189 3(13.0) 
190-234 4(17.4) 
235-279 1(4.4) 
Conversion to open surgery 
Yes 1(4.3) 
No 22(95.7) 
Platelet count response 
Positive (> 100,000/ul) 21(91.3) 
Negative (< 
100,000/ul) 
2(8.7) 
Hospital stay (days) 
1-2 8(34.8) 
3-4 15(65.2) 
 
Figure 1.Ligation of 
splenic ligaments 
with harmonic 
scalpel 
 
Figure 2. Ligation of 
splenic vessels 
 
Figure 3. Extracting 
spleen with endo 
catch 
 
Figure 4. Using 
gloves to extract 
spleen 
 
Journal of Rawalpindi Medical College (JRMC); 2018;22(2): 84-87 
 86 
 
Discussion 
After 1980s when use of laparoscopy in surgery was 
introduced, the laparoscopic instruments and 
techniques have advanced rapidly.21,22 Now the use of 
laparoscopy has become common for various intra-
abdominal surgeries,23 including the removal of 
spleen.20,23 In ITP the spleen is small with no 
hypervascularity, making it ideal for laparoscopic 
removal.18,22,24There are several studies which 
demonstrated superiority of laparoscopy over open 
surgeries in terms of post operative pain, reduced 
hospital stay, lesser morbidity and overall early 
recovery.9, 19, 20Gurdeep S. Matharoo also demonstrated 
lesser hospital stay and overall reduced morbidity and 
mortality in laparoscopic group compared to open 
splenectomty.30 
We have demonstrated less operating time, reduced  
blood loss and postoperative hospital stay and offered 
91.3% positive postoperative platelet response. 
According to many studies conducted in Asia,9,20,22,23 
the mean operating time for laparoscopic splenectomy 
ranges from 138-210 mins, which is more than the 
mean operative time of our study (i.e. 90 mins). 
Many articles suggest that laparoscopic splenectomy is 
more time consuming than open splenectomy, but 
several authors have reported that with the increase in 
experience, laparoscopic splenectomy is becoming a 
faster procedure.1,9,25 The mean operative time of our 
study is 90±22 mins whereas Qu Y et al  reported a 
mean operative time of 98±31 mins for open 
splenectomy.9 This supports the claim that 
laparoscopic splenectomy is becoming more time 
efficient. 
The mean hospital stay after laparoscopic splenectomy 
ranges from 6.3-8.9 days according to studies 
conducted in Asian hospitals.9, 20,22,23 However, we 
have achieved a shorter mean hospital stay of 3±1 days 
in our hospitals.  
Laparoscopic splenectomy offers lesser operating time, 
blood loss and hospital stay than open splenectomy. 
Moreover, it also shows that the mean operating time 
and postoperative hospital stay was lower in our study 
as compared to the laparoscopic group of Tada K et al. 
However, we observed more mean blood loss in our 
patients. The postoperative platelet response is 
comparable in our cases and the open splenectomy 
group of Tada K et al (Table 3).24  
According to a study by Chand et al there is a 15% 
incidence of pancreatic injury following a laparoscopic 
splenectomy. 26 Complication rates are 12.9% with 
open splenectomy and 9.6% with laparoscopic 
splenectomy as reported by a systematic review 
including 47 case series. 27 However, there was no 
postoperative complication in any of our patient. 
Among the intraoperative complications of 
laparoscopic splenectomy, bleeding is the main reason 
to consider a conversion to open surgery,18 specially 
when the bleeding cannot be safely and promptly 
controlled.28 We had to convert 1 case to open surgery 
due to excessive bleeding. Generally, such conversions 
become necessary in 0-22% of cases,  but do not affect 
the hematological outcome of the surgery.3,29 
Laparoscopic splenectomy is now considered to be a 
standard procedure for the secondary treatment of 
ITP.1,3,24 It is a safe and feasible procedure and 
produces better cosmetic results than open 
splenectomy.18 Hence, we wish to encourage liaison 
with hematologist and physicians to promote a culture 
of routine laparoscopic surgeries for ITP patients and 
also promote the use of laparoscopy in cases of 
splenomegaly, for which laparoscopic surgery is 
currently not widely accepted. 
 
Table 3: Laparoscopic versus open 
     splenectomy 24 
Factor Present 
Study 
Laparoscopic 
splenectomy 
group 
Open 
splenectomy 
group 
No of patients 23 22 10 
Male/Female 9/14 8/14 2/8 
Operating 
time (mins) 
90±22 150±54 104±23 
Blood loss (ml) 131±55 67±101 400±245 
Conversion to 
open 
1 None --------- 
Rise in 
platelet count 
21 
(91%) 
17 (77%) 9 (90%) 
Hospital stay 
(days) 
3±1 9±3 23±10 
Complications None 1(pancreatiti
s) 
None 
 
Conclusion 
1.Laparoscopic splenectomy is associated with less 
operating time, postoperative hospital stay, blood loss 
and postoperative complications. 
2.Laparoscopic splenectomy produces adequate 
postoperative rise in platelet count.  
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